James D. Brenton
University of Cambridge1 paperORCID 0000-0002-5738-6683OpenAlex
Papers
Nature GeneticsHumans
Germline HRD limits therapy-driven clonal hematopoiesis
Serial blood samples revealed carboplatin and PARP inhibitors expand DNA damage response clones, though germline homologous recombination deficiency…Serial blood samples revealed carboplatin and PARP inhibitors expand DNA damage response clones, though germline homologous recombination deficiency reduces this growth.